Brokerages Set Sotera Health (NASDAQ:SHC) PT at $15.70

Sotera Health (NASDAQ:SHC) has received an average rating of “Moderate Buy” from the six brokerages that are covering the company, Marketbeat Ratings reports. Two research analysts have rated the stock with a hold rating and four have given a buy rating to the company. The average 12-month price target among brokerages that have issued ratings on the stock in the last year is $15.70.

A number of equities analysts recently commented on SHC shares. Royal Bank of Canada restated an “outperform” rating and issued a $17.00 price objective on shares of Sotera Health in a report on Tuesday, August 6th. Barclays increased their price objective on Sotera Health from $14.00 to $17.00 and gave the company an “overweight” rating in a report on Tuesday, August 6th.

Sotera Health Trading Down 2.6 %

Sotera Health stock opened at $16.27 on Wednesday. The company has a quick ratio of 2.59, a current ratio of 2.93 and a debt-to-equity ratio of 5.46. Sotera Health has a 12 month low of $10.71 and a 12 month high of $17.44. The company’s fifty day simple moving average is $15.37 and its 200-day simple moving average is $12.97. The stock has a market cap of $4.61 billion, a P/E ratio of 85.64 and a beta of 2.07.

Sotera Health (NASDAQ:SHC) last issued its earnings results on Monday, August 5th. The company reported $0.19 EPS for the quarter, beating analysts’ consensus estimates of $0.15 by $0.04. Sotera Health had a return on equity of 47.26% and a net margin of 3.65%. The firm had revenue of $277.00 million for the quarter, compared to the consensus estimate of $266.45 million. During the same quarter in the previous year, the company posted $0.19 earnings per share. The business’s quarterly revenue was up 8.6% compared to the same quarter last year. As a group, sell-side analysts forecast that Sotera Health will post 0.64 EPS for the current fiscal year.

Insiders Place Their Bets

In other Sotera Health news, Director Gtcr Investment Xi Llc sold 10,000,000 shares of Sotera Health stock in a transaction on Friday, September 6th. The shares were sold at an average price of $15.03, for a total transaction of $150,300,000.00. Following the sale, the director now owns 49,215,301 shares in the company, valued at $739,705,974.03. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Corporate insiders own 55.12% of the company’s stock.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Principal Financial Group Inc. increased its position in shares of Sotera Health by 27.6% during the 1st quarter. Principal Financial Group Inc. now owns 468,500 shares of the company’s stock worth $5,627,000 after purchasing an additional 101,430 shares in the last quarter. Findell Capital Management LLC bought a new stake in Sotera Health during the fourth quarter worth about $8,425,000. P2 Capital Partners LLC increased its holdings in shares of Sotera Health by 27.0% during the fourth quarter. P2 Capital Partners LLC now owns 2,350,000 shares of the company’s stock worth $39,598,000 after buying an additional 500,000 shares in the last quarter. William Blair Investment Management LLC raised its stake in shares of Sotera Health by 0.6% in the second quarter. William Blair Investment Management LLC now owns 1,131,455 shares of the company’s stock valued at $13,430,000 after acquiring an additional 6,707 shares during the last quarter. Finally, Clearline Capital LP acquired a new position in shares of Sotera Health in the 2nd quarter worth approximately $1,707,000. Institutional investors own 91.03% of the company’s stock.

About Sotera Health

Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems.